Clotizolam | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Conformer structure via JSmol |
Physical properties [] | |
---|---|
Molecular mass | 349.2 g/mol [1] |
Predicted LogP | 2.7 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C15H10Cl2N4S [1] |
IUPAC name | 4-chloro-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene [1] |
SMILES | CC1=NN=C2N1C3=C(C=C(S3)Cl)C(=NC2)C4=CC=CC=C4Cl [1] |
InChI | InChI=1S/C15H10Cl2N4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)16)10-6-12(17)22-15(10)21(8)13/h2-6H,7H2,1H3 [1] |
InChIKey | CHGXYVPOFYZWRH-UHFFFAOYSA-N [1] |
Clotizolam
Clotizolam (also known as 2-Chloro-4-(2-chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 2-chloro-4-(2-chlorophenyl)-9-methyl-, 8-Chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo(3,4c)thieno(2,3e)-1,4-diazepine, HY-171253 or 2-chloro-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine) is a
Stereochemistry []
Clotizolam is a
Legal status
- Canada: Clotizolam is a Schedule IV substance.
- Germany: Clotizolam is a Neuer-Psychoaktiver-Stoff under the "Neue-psychoaktive-Stoffe-Gesetz (NpSG)".
- United Kingdom: Clotizolam is a PSA substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3041455, Clotizolam. Accessed June 26, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/3041455